 |
 |
 |
 |
 |
 |
 |
 |
 |
|
| Home > About TEDA > Key Industries Brief > Biological Pharmaceutic Industry | |
 Key Industries Brief |
||
 |
| Biological
Pharmaceutic Industry TIANJIN BIOPHARMICA CO., LTD.  Company Introduction:Tianjin Biopharmica Co., Ltd is joint ventured by England BIOPHARMICA Stock Company, Tianjin TEDA Venture Capital Co., LTD, Beijing Venture Capital Co., LTD and Beijing BIOPHARMICA Company, which is registered in Tianjin TEDA integrating science, industry and trade together. At present, our company has succeeded in developing out new reformed Biopharmica Transdermal Patch technology and production equipment which is listed in the top position in the field of international transdermal delivery system. Meanwhile, centralized in Transdermal Patch Delivery System, we have developed out series products as DIAPATCH, Xianketie, Xinketie, and Zhitongtie, all of which have achieved patents in America and China. In the "First Session of National Symposia on New Transdermal Technology and Herbs Modernization", our products are highly appraised by Academician Wu Jieping, vice commissioner of National People's Congress, Dr. Gary Cleary, American authority of transdermal delivery system, as well as hundreds of experts who are all attendant. Led by Mr. Ma Yanhui, who pursued his academia carrier in the diabetes researcher field in American silicon valley, experts and talents dedicate themselves much to the research of biopharmic study. Depending on advanced equipment and technology of American biological lab, they carry on scientific selection and abstraction from thousands of plants to melt China traditional medicine with western leading concept so as to invent and develop out Biopharmic Diapatch, which is the latest treatment medicine for diabetes as well as Biopharmic Xianketie for the treatment of prostatitis and hyperplasia of prostatitis.
|